Geriatric Illness And Health Studies
What is this
This trend focuses on studies addressing illnesses predominantly affecting the elderly, from physiological responses to novel dietary interventions. It integrates clinical trials and multidisciplinary research to better understand geriatric health challenges.
Why it matters
The global demographic shift toward an aging population makes understanding and addressing elderly health issues increasingly urgent. Rising healthcare costs and the burden on social systems act as key catalysts for innovation in geriatric research.
Investment angle
Investors can target healthcare companies focusing on elder care, pharmaceuticals tailored to geriatric conditions, and tech startups offering digital health solutions for seniors. Additionally, specialized healthcare ETFs and long-term investments in medical research organizations may provide steady returns.
A solid long-term opportunity with stable growth, ideal for conservative portfolios seeking healthcare exposure. Investability: 7/10.
History
| date | signals | new | substance |
|---|---|---|---|
| 2026-03-08 | 3 | 100% | |
| 2026-03-20 | 46 | +43 | 100% |
| 2026-04-01 | 47 | +1 | 100% |
| 2026-04-14 | 49 | +2 | 100% |
| 2026-04-26 | 161 | +112 | 100% |
| 2026-05-08 | 163 | +2 | 100% |
| 2026-05-22 | 166 | +3 | 100% |
| 2026-06-02 | 168 | +2 | 100% |
| 2026-06-14 | 171 | +3 | 100% |
| 2026-06-26 | 175 | +4 | 100% |
| 2026-07-08 | 177 | +2 | 100% |
| 2026-07-20 | 182 | +5 | 100% |
| 2026-08-01 | 187 | +5 | 100% |
| 2026-08-13 | 190 | +3 | 100% |
Evidence
- 2026-08-12ClinicalTrials.gov[PHASE2] HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide · detail
- 2026-08-04ClinicalTrials.gov[PHASE3] A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight · detail
- 2026-08-04ClinicalTrials.gov[PHASE3] A Study of BGM0504 in Early T2DM With Obesity · detail
- 2026-07-28ClinicalTrials.gov[PHASE4] Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial · detail
- 2026-07-28ClinicalTrials.gov[PHASE2] Semaglutide for Low Back Pain · detail
- 2026-07-27ClinicalTrials.gov[PHASE4] A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity · detail
- 2026-07-27ClinicalTrials.gov[NA] Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy · detail
- 2026-07-24ClinicalTrials.gov[PHASE2] A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity · detail
- 2026-07-20ClinicalTrials.gov[NA] Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide · detail
- 2026-07-17ClinicalTrials.gov[NA] A Two-part Study of Lembas Edge Evaluating Tolerability and Postprandial Glycemic Control · detail
- 2026-07-14ClinicalTrials.gov[] Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists · detail
- 2026-07-10ClinicalTrials.gov[] Imaging in Semaglutide Study · detail
- 2026-07-09ClinicalTrials.gov[PHASE1] Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents · detail
- 2026-07-06ClinicalTrials.gov[PHASE2] Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes · detail
- 2026-06-29EPO Patents[EPO] METHODS OF TREATING INSULIN RESISTANCE AND ASSOCIATED DISORDERS · detail
- 2026-06-25ClinicalTrials.gov[PHASE2] A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes · detail
- 2026-06-25ClinicalTrials.gov[PHASE3] A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · detail
- 2026-06-23ClinicalTrials.gov[PHASE3] A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · detail
- 2026-06-23ClinicalTrials.gov[PHASE3] A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting · detail
- 2026-06-05ClinicalTrials.gov[PHASE3] BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes · detail